Premier to be acquired by Patient Square Capital for $28.25/share in $2.6B all-cash deal

Premier, Inc.

Premier stockholders to receive $28.25 per share in cash, a 23.8% premium to 60-day VWAP as of Sep 5, 2025.
Transaction valued at approximately $2.6 billion; expected to close by Q1 2026, subject to stockholder and regulatory approvals.
Board unanimously approved; no financing condition; dividends suspended after Sept 2025 payment.
Outstanding equity awards: pre-Aug 16, 2025 RSUs/PSUs converted to cash; options cancelled for no consideration.
Termination fees: ~$66.2M if Premier terminates for superior proposal; ~$168.6M if Parent fails to close.

item 1.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.